Company news

LifeMD, Inc. news in 2024

LifeMD, Inc.'s news releases, calls and decks from 2024, newest first.

View company

LifeMD Reports Third Quarter 2024 Results

November 6, 2024

LifeMD® Launches Affiliated Pharmacy to Drive End-to-End Patient Care and Operational Efficiency

November 5, 2024

LifeMD® Launches TestoRx, a New Rex MD® Direct-to-Consumer Testosterone Replacement Therapy Telehealth Offering

October 22, 2024

LifeMD® Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

September 23, 2024

LifeMD Announces Major Enhancements to its Weight Management Program, Expanding Patient Access to Branded GLP-1 Therapies and Introducing New Treatment Options

September 18, 2024

LifeMD Reports Second Quarter 2024 Results

August 6, 2024

LifeMD Launches Commercial Health Insurance Acceptance for its Primary Care Services, Including Weight Management

June 24, 2024

LifeMD Set to Join the Russell 3000 Index

May 28, 2024

LifeMD Reports First Quarter 2024 Results; Raises Full Year Revenue Guidance

May 7, 2024

LifeMD Becomes the First Virtual Primary Care Provider to Elevate GLP-1 Patient Care with Real-time, At-Home Monitoring of Blood Pressure and Body Composition

May 1, 2024

LifeMD Appoints Dr. Calum MacRae to its Board of Directors

April 28, 2024

LifeMD to Report First Quarter 2024 Financial Results on May 8

April 23, 2024

LifeMD Reports Fourth Quarter 2023 Results

March 10, 2024

LifeMD to Report Fourth Quarter 2023 Financial Results on March 11

February 25, 2024

LifeMD Provides 2024 Financial Guidance

January 7, 2024

Calls in 2024

Decks in 2024